Annual Accounts Receivable
$26.86 M
-$1.48 M-5.21%
December 31, 2022
Summary
- As of February 10, 2025, ICPT annual accounts receivable is $26.86 million, with the most recent change of -$1.48 million (-5.21%) on December 31, 2022.
- During the last 3 years, ICPT annual accounts receivable has fallen by -$11.18 million (-29.39%).
Performance
ICPT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$32.48 M
+$2.69 M+9.02%
September 30, 2023
Summary
- As of February 10, 2025, ICPT quarterly accounts receivable is $32.48 million, with the most recent change of +$2.69 million (+9.02%) on September 30, 2023.
- Over the past year, ICPT quarterly accounts receivable has increased by +$6.31 million (+24.12%).
Performance
ICPT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ICPT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | +24.1% |
| 3 y3 years | -29.4% | -16.8% |
| 5 y5 years | +62.8% | +47.1% |
ICPT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.2% | at low | -29.6% | -19.4% |
| 5 y | 5-year | -35.3% | at low | -29.6% | -19.4% |
| alltime | all time | -35.3% | -100.0% | -29.6% | -100.0% |
Intercept Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $32.48 M(+9.0%) |
| Jun 2023 | - | $29.79 M(+3.6%) |
| Mar 2023 | - | $28.75 M(+7.0%) |
| Dec 2022 | $26.86 M(-5.2%) | $26.86 M(+2.7%) |
| Sep 2022 | - | $26.17 M(-4.9%) |
| Jun 2022 | - | $27.52 M(-40.4%) |
| Mar 2022 | - | $46.14 M(+62.8%) |
| Dec 2021 | $28.34 M(-31.8%) | $28.34 M(-38.6%) |
| Sep 2021 | - | $46.16 M(+2.0%) |
| Jun 2021 | - | $45.25 M(+6.2%) |
| Mar 2021 | - | $42.59 M(+2.5%) |
| Dec 2020 | $41.55 M(+9.2%) | $41.55 M(+6.4%) |
| Sep 2020 | - | $39.05 M(-1.8%) |
| Jun 2020 | - | $39.78 M(-9.3%) |
| Mar 2020 | - | $43.86 M(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $38.04 M(+48.1%) | $38.04 M(+15.9%) |
| Sep 2019 | - | $32.82 M(-9.7%) |
| Jun 2019 | - | $36.36 M(+23.5%) |
| Mar 2019 | - | $29.44 M(+14.6%) |
| Dec 2018 | $25.69 M(+55.7%) | $25.69 M(+16.4%) |
| Sep 2018 | - | $22.08 M(+13.2%) |
| Jun 2018 | - | $19.51 M(+15.1%) |
| Mar 2018 | - | $16.94 M(+2.7%) |
| Dec 2017 | $16.50 M(+80.8%) | $16.50 M(+13.9%) |
| Sep 2017 | - | $14.49 M(+9.5%) |
| Jun 2017 | - | $13.23 M(+24.5%) |
| Mar 2017 | - | $10.63 M(+16.4%) |
| Dec 2016 | $9.13 M(>+9900.0%) | $9.13 M(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00(-100.0%) |
| Jun 2012 | - | $472.00 K |
FAQ
- What is Intercept Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual accounts receivable year-on-year change?
- What is Intercept Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Intercept Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of ICPT is $26.86 M
What is the all time high annual accounts receivable for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual accounts receivable is $41.55 M
What is Intercept Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, ICPT annual accounts receivable has changed by -$1.48 M (-5.21%)
What is Intercept Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of ICPT is $32.48 M
What is the all time high quarterly accounts receivable for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly accounts receivable is $46.16 M
What is Intercept Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, ICPT quarterly accounts receivable has changed by +$6.31 M (+24.12%)